Built upon 20+ years of category-specific experience, we are dedicated to elevating the standard of dermatology drug development with clarity, collaboration and insight. Therapeutics, Inc., the dermatology CRO authority, navigates the complex maze of non-clinical, clinical and regulatory hurdles to deliver integrated, turnkey solutions built for your unique requirements, from concept to commercialization.
Labskin’s pioneering approach to testing skin care products by cloning a patient’s skin microbiome and transplanting it on to Labskin human skin equivalent allows a wide range of testing that no longer requires invasive procedures on patients. Data from next generation sequencing of the Labskin and skin biome is coupled with AI processes to interpret and direct further development of skincare products in a controlled and efficient manner, reducing development time and costs.
Eagle Genomics applies network science to biology to reveal the impact of the microbiome on humans, animals and the environment to secure a sustainable future for our food, water, soil and the health of our planet. The e[datascientist]™ platform transforms scientists’ journey to insights, unifying constellations of complex, multi-dimensional data (the data fabric) to explore and extract signals and networks of relationship, otherwise not detectable by humans alone.
Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 accredited world class pharmaceutical testing laboratory. We provide identity, purity, and potency analyses necessary to characterize microbiome products and we have a proven track record on a variety of Microbiome programs including Spore Fraction and Defined Drug Product manufacturing processes. Boston Analytical employs LabWare Inc.’s™ LIMS and ELN software to help ensure on-time and accurate results.